Apathy is defined as a quantitative reduction in voluntary and goal-directed behavior. To address this, the investigators propose an ethological approach to assess apathy objectively and quantitatively by observing patients in real-life situations. The ECOCAPTURE paradigm involves a structured, multi-step scenario conducted in a functional exploration platform. This platform is equipped with an advanced data acquisition system integrating video recordings and sensors to precisely monitor and analyze participants' behavior. Primary objective: Develop a diagnostic tool for apathy using metrics derived from video recordings and sensor data. This tool aims to provide objective measures to identify and quantify apathy. Secondary Objectives: * Validation of ICM\_APATHY\_TASKS: This novel experimental task is designed to evaluate three primary mechanisms thought to underlie apathy: Motivation, Cognitive inertia (difficulty initiating tasks), The interaction between motivation and action execution. * Identification of the pathophysiological mechanisms of apathy by investigate the cognitive, behavioral, neural, and neurohormonal underpinnings of apathy. This will enable the classification of apathetic patients into subtypes (or several forms of apathy) based on the dominant mechanisms and provide insights into which processes best explain apathy in individual cases. This innovative framework aims to deepen the understanding of apathy, improve diagnostic precision, and pave the way for tailored interventions.
A pilot study, ECOCAPTURE (ClinicalTrials.gov/NCT02496312, 2015), was conducted with participants diagnosed with the behavioral variant of frontotemporal dementia (bvFTD) matched for age, gender, and education level with healthy controls (n=7 per group). This study successfully validated the feasibility and conceptual framework of the ECOCAPTURE approach. The aim of this trial is to further develop and expand the ECOCAPTURE tool by applying it to a larger population, including individuals with the behavioral variant of frontotemporal dementia (bvFTD) and healthy control participants. The objectives of this study are to evaluate goal-directed behavior and identify apathy by analyzing data to establish a behavioral signature of apathy. Additionally, the study seeks to refine patient profiles by delineating the pathophysiological mechanisms underlying apathy, including cognitive processes, neural substrates, and neurohormonal pathways. The experiments take place on an experimental platform dedicated to the functional exploration of human behavior (PRISME, ICM core facility, Salpêtrière Hospital, Paris, France), to assess behavior under ecological conditions. The ECOCAPTURE paradigm mimics a naturalistic situation (i.e., waiting comfortably in a waiting room). Participants undergo a structured 45-minute controlled scenario, during which their behavior is systematically monitored to evaluate apathy and disinhibition. The PRISME platform is transformed into a furnished waiting room containing specific objects that provides opportunities to interact with the environment. The platform is equipped with a six-ceiling camera system (not hidden) covering the entire waiting room. The Media Recorder® software (NOLDUS Information Technology, Wageningen, the Netherlands) facilitates simultaneous video recordings from multiple cameras, ensuring synchronized capture across different viewpoints for comprehensive behavioral analysis. During the experiment, individuals' behavior is video-recorded, and their movement acceleration is measured using a wireless body sensor (Move II® triaxial accelerometer, Movisens GmbH, Karlsruhe, Germany) worn on the right hip. An eye-tracking system (SMI Eye Tracking Glasses 2 Wireless, ®SensoMotoric Instruments, Teltow, Germany / Tobii Pro Glasses 3, ®Tobii AB, Danderyd, Sweden) is added to the multimodal recording system, and the subjects wear eye-tracking glasses for a 7-minute period during the 45-minute experimental session. The subjects are informed at the time of initial consent that their behavior would be tracked and recorded by video cameras located in the room. Video data analysis is performed with The Observer XT software (Version 14.0, NOLDUS, Wageningen, The Netherlands) to identify the frequency and duration of behaviors. Behavioral metrics are obtained by behavioral coding from 45-minute video footage for each individual. Behavioral coding data is collected through the continuous sampling method, to identify all occurrences of behaviors and their duration. Behavioral coding is conducted based on two ethograms - the ECOCAPTURE apathy ethogram, the ECOCAPTURE disinhibition ethogram - (Batrancourt et al. 2022, "The ECOCAPTURE ethograms: apathy ethogram and disinhibition ethogram", Mendeley Data, V2, doi: 10.17632/mv8hndcd95.2) The ECOCAPTURE apathy ethogram includes behaviors divided in two behavioral categories: Motor patterns, Activity states. The ECOCAPTURE disinhibition ethogram includes behaviors divided in three disinhibition categories: Compulsivity, Impulsivity, Social disinhibition. Metrics built from collected data (video, sensors) are analyzed to reveal a behavioral signature of apathy. The study consists of two separate visits, each occurring on a different day, and includes the following components: the ECOCAPTURE observation phase in ecological conditions, a comprehensive neuropsychological assessment, a series of experimental tasks (some of which are computer-based), an MRI scan (including T1, T2, rs-fMRI, and MS-DWI), and a blood sample collection.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
66
45 minutes observational session for tracking goal directed behavior into a waiting room equipped with video and sensor-based data acquisition system
Cognitive and Behavioral experimental tasks to explore additional frontal cognitive and behavioral dimensions and functions
STARKSTEIN APATHY SCALE (SAS) / DAS / MMSE / MADRS / EBI / MINI-SEA / FAB / HAD / MATTIS / HAYLING / STROOP / Verbal Span / Lexical verbal fluency / TMT / CDRS
Apathy experimental task
T1 / T2 / rs-fMRI / MS-DWI
Hormonal dosage / Diabetic dosage / Ionogramme dosage / Inflammatory dosage / Hepatic dosage / Lipidic dosage / Thyroid dosage
Paris Brain Institute / ICM / Pitié-Salpêtrière Hospital AP-HP / CIC
Paris, France
Frequency of each behavior in the ECOCAPTURE ethogram
\[Tracking specific behaviors as outlined in the ECOCAPTURE ethogram. Behavioral metrics are derived from coding the behaviors observed in 45-minute video footage, based on the structured ethogram\] integer. .
Time frame: 45 min
Occurrence of each behavior in the ECOCAPTURE ethogram
\[Tracking specific behaviors as outlined in the ECOCAPTURE ethogram. Behavioral metrics are derived from coding the behaviors observed in 45-minute video footage, based on the structured ethogram\] integer. .
Time frame: 45 min
Duration of each behavior in the ECOCAPTURE ethogram
\[Tracking specific behaviors as outlined in the ECOCAPTURE ethogram. Behavioral metrics are derived from coding the behaviors observed in 45-minute video footage, based on the structured ethogram\] integer. .
Time frame: 45 min
Activity classes
\[Provided by the accelerometer sensor\] Activity class: Indicates the physical position of the subject (unknown position = 0, lying down = 1, sitting/standing = 2, vertical movement upwards = 4, fast movement = 5, vertical movement downwards = 6, walking = 7)
Time frame: 45 min
Body positions
\[Provided by the accelerometer sensor\] Body position: Specifies the characteristics of the lying position (unknown position = 0, lying on the back = 1, lying on the left side = 2, lying on the stomach = 3, lying on the right side = 4, getting up = 5).
Time frame: 45 min
Steps
\[Provided by the accelerometer sensor\] Counting steps.
Time frame: 45 min
Energy expenditure
\[Provided by the accelerometer sensor\] Energy expenditure during activity phases. kcal.
Time frame: 45 min
MET
\[Provided by the accelerometer sensor\] The Metabolic Equivalent of Task: MET level.
Time frame: 45 min
Acceleration intensity
\[Provided by the accelerometer sensor\] g.
Time frame: 45 min
Pupil Diameter x,y
\[Provided by the eye-tracking glasses\] mm, mm.
Time frame: 7 min
Ocular events
\[Provided by the eye-tracking glasses\] Saccades, Fixations and Blink frequency.
Time frame: 7 mn
Gaze points
\[Provided by the eye-tracking glasses\] Individual records of the participant's gaze at any given moment
Time frame: 7 mn
STARKSTEIN (SAS)
\[Part of the neuropsychological assessment - Starkstein Apathy Scale\] SAS global score
Time frame: 10 mn
DAS
\[Part of the neuropsychological assessment\] - Dimensional Apathy Scale - DAS global score - DAS initiation score - DAS executive score - DAS emotional score.
Time frame: 10 mn
ICM_APATHY_TASKS
ICM\_APATHY\_TASKS global score. \[The ICM\_APATHY\_TASKS test three main presumed mechanisms of apathy: lack of motivation, cognitive inertia, and the decoupling between motivation and action. These tasks integrate two orthogonal dimensions: 1/ The cognitive dimension: modulation of the level of cognitive strategy (to study cognitive inertia); 2/ The motivational dimension: modulation of the reward at stake (to study lack of motivation)\].
Time frame: 1 hour
MMSE
\[Part of the neuropsychological assessment\] - Mini Mental State Exam - MMSE global score
Time frame: 5 mn
MADRS
\[Part of the neuropsychological assessment\] - Montgomery-Åsberg Depression Rating Scale - MADRS global score
Time frame: 10 mn
EBI
\[Part of the neuropsychological assessment\] - Eating Behavior Inventory - EBI scores. \[Food behavior questionnaire. This refers to an assessment tool designed to evaluate a person's eating behaviors and identify potential risks, such as choking or aspiration, during eating\].
Time frame: 15 mn
MATTIS
\[Part of the neuropsychological assessment\] - Mattis Dementia Rating Scale - MATTIS global score
Time frame: 20 mn
FAB
\[Part of the neuropsychological assessment\] - Frontal Assessment Battery - FAB global score \[French version: BREF\].
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 10 mn
HAYLING
\[Part of the neuropsychological assessment\] - Hayling Sentence Completion test - HAYLING B-A score
Time frame: 15 mn
HAD
\[Part of the neuropsychological assessment\] Hospital Anxiety and Depression Scale - HAD global score
Time frame: 10 mn
STROOP
\[Part of the neuropsychological assessment\] - STROOP - STROOP global score
Time frame: 3 mn
Mini-SEA
\[Part of the neuropsychological assessment\] - Mini Social cognition and Emotional Assesment - Mini-SEA global score
Time frame: 20 mn
Verbal Span / Lexical verbal fluency
\[Part of the neuropsychological assessment\] - Verbal Span / Lexical verbal fluency - Verbal scores
Time frame: 7 mn
CDRS
\[Part of the neuropsychological assessment\] - Clinical Dementia Rating (CDR) Scale - CDRS global score
Time frame: 5 mn
Gray matter volume
\[MRI analysis- Brain segmentation\] mm3
Time frame: MRI exam: 48 mn
White matter volume
\[MRI analysis- Brain segmentation\] mm3
Time frame: MRI exam: 48 mn
Cortical Thickness
\[MRI analysis- Brain segmentation\] mm
Time frame: MRI exam: 48 mn
Resting-State Connectivity
\[fMRI analysis\] - strength and significance of the connection between different regions.
Time frame: MRI exam: 48 mn
IL-6
Hormonal result \[Interleukin-6\] pg/mL
Time frame: Blood sample collection - 30 mn
Leptin
Hormonal result \[Leptin\] ng/mL
Time frame: Blood sample collection - 30 mn
Adiponectin
Hormonal result \[Blood adiponectin level)\] mg/L
Time frame: Blood sample collection - 30 mn
Insulin
Hormonal result \[Fasting Insulin\] mUI/L
Time frame: Blood sample collection - 30 mn
C-Peptide
Diabetic result \[Fasting C-Peptide level\] µg/L
Time frame: Blood sample collection - 30 mn
FPG
Diabetic result \[Fasting Plasma Glucose\] mmol/L
Time frame: Blood sample collection - 30 mn
HbA1C
Diabetic result \[Glycated Hemoglobin\] %
Time frame: Blood sample collection - 30 mn
Sodium
Ionogram result \[Sodium\] mmol/L
Time frame: Blood sample collection - 30 mn
K+
Ionogram result \[Potassium\] mmol/L
Time frame: Blood sample collection - 30 mn
Uric acid
Ionogram result \[Uric acid\] µmol/L
Time frame: Blood sample collection - 30 mn
Creatinine
Ionogram result \[Creatinine\] µmol/L
Time frame: Blood sample collection - 30 mn
Total Protein
Ionogram result \[Total protein\] g/L
Time frame: Blood sample collection - 30 mn
CRP
Inflammatory result \[C-reactive protein\] mG/L
Time frame: Blood sample collection - 30 mn
AST
Hepatic result \[Aspartate aminotransferase\] U/L
Time frame: Blood sample collection - 30 mn
ALT
Hepatic result \[Alanine aminotransferase\] U/L
Time frame: Blood sample collection - 30 mn
GGT
Hepatic result \[Gamma-glutamyltransferase\] U/L
Time frame: Blood sample collection - 30 mn
Cholesterol
Lipidic result \[Total cholesterol\] mmol/L
Time frame: Blood sample collection - 30 mn
Triglycerides
Lipidic result \[Triglycerides\] mmol/L
Time frame: Blood sample collection - 30 mn
HDL cholesterol
Lipidic result \[High-density lipoprotein cholesterol\] mmol/L
Time frame: Blood sample collection - 30 mn
LDL cholesterol
Lipidic result \[Low-density lipoprotein cholesterol\] mmol/L
Time frame: Blood sample collection - 30 mn
Glycerol
Lipidic result \[Plasma glycerol concentration\] mmol/L
Time frame: Blood sample collection - 30 mn
FFAs
Lipidic result \[Plasma free fatty acids\] mmol/L
Time frame: Blood sample collection - 30 mn
TSH
Thyroid result \[Thyroid-stimulating hormone blood test\] mmol/L
Time frame: Blood sample collection - 30 mn